Literature DB >> 6987261

Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin.

E Kjems, B Perch, J Henrichsen.   

Abstract

A total of 252 strains of group B streptococci were serotyped and examined for their ability to ferment lactose (lac+), to hydrolyze salicin (sal+), and to produce hyaluronidase (hy+). Of these strains, 67 had been isolated from bacteremia and meningitis in infants less than 2 months old. Eighty-one strains were isolated from bacteremia and meningitis in adults, and 104 strains were from various other infections. Type III was the most common in neonatal disease, especially if isolates from cases of bacteremia in infants less than 10 days of age were not included. Only 6% of the strains were lac+. Sal+/hy+ strains were never type III, but 91% of the strains belonging to the other serotypes were sal+/hy/. Results showed that 81% of the sal+/hy- strains and 95% of the sal-/hy+ strains were type III, and sal-/hy+ strains were more than twice as frequent as sal+/hy- strains in serious neonatal infections, in contrast to the other two disease groups, in which the opposite was found to be the case. These reactions may be used as additional markers in epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987261      PMCID: PMC273333          DOI: 10.1128/jcm.11.2.111-113.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  New serotypes of group B streptococci isolated from human sources.

Authors:  B Perch; E Kjems
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

2.  Streptococcal hyaluronidase; review and the turbidimetric method for its determination.

Authors:  V FABER
Journal:  Acta Pathol Microbiol Scand       Date:  1952

3.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.

Authors:  C J Baker; F F Barrett; R C Gordon; M D Yow
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

4.  Type classification of the group B streptococci by means of Lancefield's precipitin method. Classification of strains of bovine and human origin; isolated during the year 1971 in Norway.

Authors:  R H Haug
Journal:  Nord Vet Med       Date:  1972-12

5.  Isolation of hyaluronic acid from cultures of streptococci in a chemically defined medium.

Authors:  E Kjems; K Lebech
Journal:  Acta Pathol Microbiol Scand B       Date:  1976-06

Review 6.  Summary of the workshop on perinatal infections due to group B Streptococcus.

Authors: 
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

7.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

  7 in total
  6 in total

1.  Group B streptococcal neuraminidase is actually a hyaluronidase.

Authors:  D G Pritchard; B Lin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

2.  Protease production by clinical isolates of type III group B streptococci.

Authors:  D C Straus; S J Mattingly; T W Milligan; T I Doran; T J Nealon
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

3.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

4.  Group B Streptococcus Evades Host Immunity by Degrading Hyaluronan.

Authors:  Stacey L Kolar; Pierre Kyme; Ching Wen Tseng; Antoine Soliman; Amber Kaplan; Jiurong Liang; Victor Nizet; Dianhua Jiang; Ramachandran Murali; Moshe Arditi; David M Underhill; George Y Liu
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

5.  Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.

Authors:  D L Durham; S J Mattingly; T I Doran; T W Milligan; D C Straus
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

6.  Lysis of erythrocytes by a hemolysin produced by a group B Streptococcus sp.

Authors:  B A Marchlewicz; J L Duncan
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.